NCT02013336: Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors |
|
|
| Recruiting | 1 | 30 | US | MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide | South Plains Oncology Consortium | Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma, Neuroblastoma, Osteosarcoma | 12/23 | 12/23 | | |
